Healthcare provider profile · identity verified

Ma. Dina Javier Santos, M.D.

Internal Medicine · SAN LEANDRO, CA · NPI 1073667721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	186
Amlodipine Besylate	Amlodipine Besylate	440	145
Losartan Potassium	Losartan Potassium	411	131
Lisinopril	Lisinopril	256	87
Metformin Hcl Er	Metformin Hcl	221	77
Atenolol	Atenolol	198	64
Simvastatin	Simvastatin	171	57
Levothyroxine Sodium	Levothyroxine Sodium	167	46
Alendronate Sodium	Alendronate Sodium	160	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	36
Rosuvastatin Calcium	Rosuvastatin Calcium	121	42
Hydrochlorothiazide	Hydrochlorothiazide	119	42
Albuterol Sulfate Hfa	Albuterol Sulfate	116	64
Metoprolol Tartrate	Metoprolol Tartrate	104	32
Jardiance	Empagliflozin	98	35
Famotidine	Famotidine	95	33
Allopurinol	Allopurinol	94	33
Fluticasone Propionate	Fluticasone Propionate	87	30
Furosemide	Furosemide	84	28
Omeprazole	Omeprazole	81	33
Trazodone Hcl	Trazodone Hcl	81	24
Tamsulosin Hcl	Tamsulosin Hcl	79	21
Hydralazine Hcl	Hydralazine Hcl	76	27
Glipizide Er	Glipizide	73	29
Metoprolol Succinate	Metoprolol Succinate	72	23
Triamcinolone Acetonide	Triamcinolone Acetonide	65	34
Alvesco	Ciclesonide	63	30
Lovastatin	Lovastatin	62	21
Metformin Hcl	Metformin Hcl	56	25
Glipizide	Glipizide	55	22
Gabapentin	Gabapentin	50	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	19
Carvedilol	Carvedilol	44	14
Ibuprofen	Ibuprofen	44	17
Ozempic	Semaglutide	44	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	40	13
Fluoxetine Hcl	Fluoxetine Hcl	38	17
Humulin N	Insulin Nph Human Isophane	37	15
Hydrocortisone	Hydrocortisone	37	14
Colchicine	Colchicine	36	16
Duloxetine Hcl	Duloxetine Hcl	36	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	35	16
Naproxen	Naproxen	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Baclofen	Baclofen	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	12
Ondansetron Hcl	Ondansetron Hcl	30	14
Buspirone Hcl	Buspirone Hcl	28	suppressed
Sertraline Hcl	Sertraline Hcl	28	12
Lorazepam	Lorazepam	27	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	23	11
Fluocinonide	Fluocinonide	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Prednisone	Prednisone	20	14
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Cefadroxil	Cefadroxil	19	19
Levetiracetam	Levetiracetam	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Azithromycin	Azithromycin	18	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	16	15
Bupropion Xl	Bupropion Hcl	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Meloxicam	Meloxicam	16	11
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	12	12
Chlorthalidone	Chlorthalidone	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Finasteride	Finasteride	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error